TLSA (Tiziana Life Sciences Ltd.) Sof foyda

TLSA (Tiziana Life Sciences Ltd) - kompaniyaning tovar belgisi

Tiziana Life Sciences (TLSA) maxsus tashuvchilar orqali optimallashtirilgan biomaterial transport zanjirlaridan foydalangan holda ilg'or himoya sog'liqni saqlash yechimlarini ishlab chiqadi. Aksiyalar narxining ushbu grafigi joriy qiymat -0.03 ekanligini aks ettiradi. Moliyaviy model kapitalni jalb qilishga tayanadi, chunki yangi mahsulotlarning sinov bosqichi ularning tijoratlashtirilishigacha barqaror daromad olish imkoniyatini cheklaydi.

TLSA (Tiziana Life Sciences) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

Tiziana Life Sciences Ltd (TLSA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Tiziana Life Sciences, Ltd.|TLSA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Tiziana Life Sciences, Ltd.|TLSA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Tiziana Life Sciences|TLSA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi tizianalifesciences.com|TLSA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Tiziana Life Sciences|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Tiziana Life Sciences Ltd.|TLSA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Tiziana Life Sciences, Ltd.|TLSA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Tiziana Life Sciences|Shoshilinch likvidlik tizianalifesciences.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
TLSA - Sof daromad
Kompaniyaning jamlanma tahlili:Tiziana Life Sciences
Tiziana Life Sciences PLC asosiy tovari

Tiziana Life Sciences foydasi barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiradi. Ushbu ko'rsatkich investorlarga bozor shovqinlarini filtrlash va biznesning haqiqiy samaradorligini baholash imkonini beradi. Kompaniyaning sof iqtisodiy effektini tahlil qilish orqali daromadlilikning tarixiy cho'qqilari va pasayishlarini aniqlash mumkin. Tiziana Life Sciences (TLSA) uchun ushbu ko'rsatkich noyob patentlarni monetizatsiya qilish qobiliyatini tasdiqlaydi. Antitelalarni yetkazib berish usullari bo'yicha monopol narx belgilash kuchi kelgusidagi foyda o'sishini bevosita belgilaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|Pharming Corp - Soliqlar to‘langandan keyingi foyda|NKTR: Sof foyda|UPB - Sof moliyaviy natija|Sof daromad ZBIO|Immunome Inc - Soliqdan keyingi foyda|Sof foyda GOSS|Sof moliyaviy natija KalVista Corp|Sof foyda SEPN (Septerna Inc)|Sof foyda pieris.com PVLA|SVRA - Kompaniyaning sof foydasi|RIGL (Rigel Pharma) - Kompaniya foydasi|ANAB: Sof foyda|Astria Corp (ATXS) - Sof foyda|Sof daromad ENGN|RAPT: Yakuniy foyda|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|Kompaniyaning sof foydasi ACRS (Aclaris Therapeutics Inc.)|Sof foyda KYTX (Kyverna)|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|Ventyx Biosciences - Sof foyda|Soliqdan keyingi foyda THTX|AVTX: Sof foyda|Kompaniyaning sof daromadi Eledon Pharmaceuticals Inc. (ELDN)|Sof daromad AGEN|CLYM: Yakuniy foyda|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|Sof moliyaviy natija atyrpharma.com|Sof foyda ADAG (Adagene Inc.)|IMA - Sof daromad|Shattuck Therapeutics - Sof foyda|Sof moliyaviy natija Equillium, Inc. EQ|CNTB: Sof foyda|Kompaniyaning sof daromadi Immunic (IMUX)|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|Kompaniya foydasi IFRX (InflaRx GmbH)|Sof foyda XFOR|Sof daromad adicetbio.com ACET|Sof foyda CELU (Celularity)|inmunebio.com (INMB) - Kompaniyaning sof daromadi|BRNS - Kompaniyaning sof foydasi|Sof moliyaviy natija Kezar Life Sciences Inc. KZR|SABS (SAB Biotherapeutics, Inc) - Sof daromad|AKTX: Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Kompaniyaning sof foydasi QTTB|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof moliyaviy natija Edesa Biotech Inc|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Soliqdan keyingi foyda BOLT|HCWB: Sof foyda|Aptevo Therapeutics Inc. - Yakuniy foyda|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|XRTX (xortx.com) - Yakuniy foyda|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB - Sof daromad|Indaptus - Sof foyda|SCNI - Sof foyda|CALI (calcimedica.com) - Sof daromad|Affimed N.V. - Yakuniy foyda|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD: Sof daromad